Western blot analysis results showed that interferon gamma treated ALST and OVCA5 ovarian cancer cells had a significant decrease in phosphorylated ERK and P38MAPK protein levels when compared to control solvent treated cells (Figure 5D). This evidence concerns the gene MAPK1 and ovarian carcinoma.